DOJ Launches Whistleblower Rewards Program for Antitrust Crimes

October 7, 2025

DOJ Launches Whistleblower Rewards Program for Antitrust Crimes

The Department of Justice (DOJ) has announced a significant new initiative to combat anticompetitive practices and market manipulation: a whistleblower rewards program specifically targeting antitrust crimes.

For individuals with knowledge of such illicit activities, this represents an opportunity to not only bring wrongdoers to justice but also potentially receive substantial monetary rewards.

Understanding the New Whistleblower Payout Program

The program focuses on antitrust crimes, from price-fixing and bid-rigging to market allocation schemes that stifle competition and inflate costs.

Like qui tam litigation under the federal False Claims Act, this new DOJ program is a testament to the growing recognition of whistleblowers as indispensable allies in the fight against fraud and corruption. The program is a collaboration between the DOJ’s Antitrust Division and the U.S. Postal Service (USPS) and the U.S. Postal Inspection Service (USPIS).

 

Why This Matters

Antitrust crimes often occur behind closed doors, making detection and prosecution difficult. The new program is designed to break through these walls of secrecy by encouraging whistleblowers—employees, contractors, and others with firsthand knowledge—to come forward voluntarily.

The whistleblower rewards program specifically targets sectors like healthcare, agriculture, technology, and government procurement. As the DOJ noted, price fixing and bid rigging can distort the competitive process, driving up costs for consumers and taxpayers alike.

Whistleblowers may be eligible for financial rewards if they provide original, credible, and timely information that leads to DOJ enforcement actions recovering at least $1 million in criminal fines. Potential whistleblower payouts range from 15% to 30% of those fines.

Examples of Healthcare-Related Antitrust Activity

Anticompetitive Mergers and Acquisitions

When healthcare companies consolidate—such as hospitals, insurers or private equity firms—they often claim they’re creating efficiencies. But if these mergers reduce competition, they may lead to:

  • Higher prices
  • Lower quality of care
  • Limited access
  • Fewer jobs

Examples of these tactics include:

A private equity firm buys up nursing homes or clinics in one area and influences providers to fix prices.

  • A health insurer acquires competing medical groups and blocks them from contracting with rival insurers.
  • A hospital system buys other hospitals and directs referrals only within its network.
  • Acquired providers change billing codes to overcharge without improving care.

Employment Restrictions That Limit Competition

Some healthcare employers make agreements that restrict workers’ ability to switch jobs or negotiate better terms. These practices may be illegal.

Examples:

  • Employers agree not to hire each other’s workers or to set the same wages and benefits.
  • Employers share wage info or divide up the local workforce.

Price Fixing, Bid Rigging, and Market Allocation

When competitors agree on pricing, bidding strategies or who serves which customers, it limits competition and often drives up costs.

Examples:

  • Providers or drug companies agree to set prices or reimbursement rates.
  • Competing hospitals agree to serve only certain regions or clients.
  • Companies take turns winning bids or only bid on certain projects.

Standing Up to Fraud Against the Government

At Waters Kraus Paul & Siegel, our Dallas, Texas-based whistleblower attorneys have spent over two decades representing individuals across the country who bravely report fraud—from false billing and kickback schemes to government contract abuse. If you’ve witnessed fraud committed against the government, our firm can help you take a stand and protect your rights under the False Claims Act.

Our Results

$880 million award

Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.

READ THE DETAILS

$725.5 million award

A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.

READ THE DETAILS

$25 million award

Private equity firm and co-defendants agree to pay $25M in Medicaid fraud case alleging mental health services provided by unqualified providers.

READ THE DETAILS